Velarion · Company Intelligence
Compensation Brief
Fiscal year 2025 · Filings through 2026-07-22

Quanterix Corp (QTRX)

Fiscal year 2025 executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.

$5,250,745
Masoud Toloue total, FY2025
43rd
CEO pay percentile vs peers
44:1
CEO-to-median pay ratio
87.7%
Say-on-pay support, latest vote
Companies that benchmark against QTRX
13 companies name QTRX as a compensation peer

Each company listed discloses QTRX in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named QTRX in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.

01

Summary Compensation Table — fiscal year 2025

Named executive officerSalaryBonusStock awardsOption awardsNon-equity incentivePension / NQDCAll otherTotal
Masoud Toloue$670,950$0$1,170,000$2,729,998$674,172$0$5,625$5,250,745
Former President and Chief Executive Officer
Vandana Sriram462,2520427,502997,500309,225015,7502,212,229
Chief Financial Officer and Treasurer
William Donnelly19,321080,001408,1100089,410596,842
Former Executive Chair

A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.

Three-year trend — total compensation per named executive

Named executive officerFY2025 totalFY2024 totalFY2023 totalΔ FY20242025
Masoud Toloue$5,250,745$6,433,027$5,435,274−1,182,282
Vandana Sriram2,212,2292,617,5231,099,153−405,294
William Donnelly596,842

Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.

02

Equity transactions since the proxy statement was filed

Every insider equity transaction reported on Form 4 after the 2025 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.

InsiderRoleTransaction dateCodeSharesPriceValueSecuritySource
Michael Francis MillerChief Operating Officer2026-04-30D39$3$122CommonForm 4 ↗
Michael Francis MillerChief Operating Officer2026-04-30A130CommonForm 4 ↗
Dividend-equivalent accruals2026-04-301301 insider, 1 accrual row
Benjamin MeadowsChief Commercial Officer2026-05-12A3,50039,695CommonForm 4 ↗
Vandana SriramChief Financial Officer2026-05-15A1,056CommonForm 4 ↗
Michael Francis MillerChief Technology Officer2026-05-15A81CommonForm 4 ↗
Michael Francis MillerChief Technology Officer2026-05-15A135CommonForm 4 ↗
Michael Francis MillerChief Technology Officer2026-05-15D413113CommonForm 4 ↗
Michael Francis MillerChief Technology Officer2026-05-15D2493685CommonForm 4 ↗
Dividend-equivalent accruals2026-05-153,3912 insiders, 8 accrual rows
Michael Francis MillerChief Technology Officer2026-05-15D1113305CommonForm 4 ↗
Michael Francis MillerChief Technology Officer2026-05-15A372CommonForm 4 ↗
Michael Francis MillerChief Technology Officer2026-05-15D25369CommonForm 4 ↗
Vandana SriramChief Financial Officer2026-05-15A514CommonForm 4 ↗
Michael Francis MillerChief Technology Officer2026-05-15A834CommonForm 4 ↗
Michael Francis MillerChief Technology Officer2026-05-15A136CommonForm 4 ↗
Michael Francis MillerChief Technology Officer2026-05-15D413113CommonForm 4 ↗
Vandana SriramChief Financial Officer2026-05-15A263CommonForm 4 ↗
Vandana SriramChief Financial Officer2026-05-15D793217CommonForm 4 ↗
Vandana SriramChief Financial Officer2026-05-15D1543424CommonForm 4 ↗
Vandana SriramChief Financial Officer2026-05-15D3153866CommonForm 4 ↗
Dividend-equivalent accruals2026-05-311301 insider, 1 accrual row
Michael Francis MillerChief Technology Officer2026-05-31A130CommonForm 4 ↗
Michael Francis MillerChief Technology Officer2026-05-31D393119CommonForm 4 ↗
Michael Francis MillerChief Technology Officer2026-06-15D25378CommonForm 4 ↗
Michael Francis MillerChief Technology Officer2026-06-15D413127CommonForm 4 ↗
Dividend-equivalent accruals2026-06-153,3912 insiders, 8 accrual rows
Michael Francis MillerChief Technology Officer2026-06-15D2493772CommonForm 4 ↗
Vandana SriramChief Financial Officer2026-06-15A263CommonForm 4 ↗
Vandana SriramChief Financial Officer2026-06-15D1543477CommonForm 4 ↗
Michael Francis MillerChief Technology Officer2026-06-15A136CommonForm 4 ↗
Michael Francis MillerChief Technology Officer2026-06-15A135CommonForm 4 ↗
Michael Francis MillerChief Technology Officer2026-06-15D413127CommonForm 4 ↗
Michael Francis MillerChief Technology Officer2026-06-15A372CommonForm 4 ↗
Michael Francis MillerChief Technology Officer2026-06-15D1113344CommonForm 4 ↗
Michael Francis MillerChief Technology Officer2026-06-15A834CommonForm 4 ↗
Vandana SriramChief Financial Officer2026-06-15D793245CommonForm 4 ↗
Vandana SriramChief Financial Officer2026-06-15A1,056CommonForm 4 ↗
Vandana SriramChief Financial Officer2026-06-15A514CommonForm 4 ↗
Vandana SriramChief Financial Officer2026-06-15D3153977CommonForm 4 ↗
Michael Francis MillerChief Technology Officer2026-06-15A81CommonForm 4 ↗
Michael Francis MillerChief Technology Officer2026-06-30A130CommonForm 4 ↗
Dividend-equivalent accruals2026-06-301301 insider, 1 accrual row
Michael Francis MillerChief Technology Officer2026-06-30D394168CommonForm 4 ↗
Scott MendelDirector2026-07-01A3,456414,999CommonForm 4 ↗
William P. DonnellyDirector2026-07-01A5,472423,748CommonForm 4 ↗
Goldman Myla LaiDirector2026-07-08A8,073CommonForm 4 ↗
Scott MendelDirector2026-07-08D8,07300Derivative, Class A CommonForm 4 ↗
Scott MendelDirector2026-07-08A8,073CommonForm 4 ↗
Goldman Myla LaiDirector2026-07-08D8,07300Derivative, Class A CommonForm 4 ↗
Michael Francis MillerChief Technology Officer2026-07-15A136CommonForm 4 ↗
Dividend-equivalent accruals2026-07-151,5581 insider, 5 accrual rows
Michael Francis MillerChief Technology Officer2026-07-15D254106CommonForm 4 ↗
Michael Francis MillerChief Technology Officer2026-07-15D1114471CommonForm 4 ↗
Michael Francis MillerChief Technology Officer2026-07-15A81CommonForm 4 ↗
Michael Francis MillerChief Technology Officer2026-07-15D414174CommonForm 4 ↗
Michael Francis MillerChief Technology Officer2026-07-15D24941,056CommonForm 4 ↗
Michael Francis MillerChief Technology Officer2026-07-15A834CommonForm 4 ↗
Michael Francis MillerChief Technology Officer2026-07-15A372CommonForm 4 ↗
Jason F. FaesslerChief Financial Officer2026-07-15A141,82000Derivative, Class A CommonForm 4 ↗
Michael Francis MillerChief Technology Officer2026-07-15D414174CommonForm 4 ↗
Michael Francis MillerChief Technology Officer2026-07-15A135CommonForm 4 ↗

Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.

View all 80 transactions
InsiderRoleTransaction dateCodeSharesPriceValueSecuritySource
Michael Francis MillerChief Operating Officer2026-04-30D39$3$122CommonForm 4 ↗
Michael Francis MillerChief Operating Officer2026-04-30A130CommonForm 4 ↗
Michael Francis MillerChief Operating Officer2026-04-30D13000Derivative, Class A CommonForm 4 ↗
Benjamin MeadowsChief Commercial Officer2026-05-12A3,50039,695CommonForm 4 ↗
Vandana SriramChief Financial Officer2026-05-15A1,056CommonForm 4 ↗
Michael Francis MillerChief Technology Officer2026-05-15A81CommonForm 4 ↗
Michael Francis MillerChief Technology Officer2026-05-15A135CommonForm 4 ↗
Michael Francis MillerChief Technology Officer2026-05-15D413113CommonForm 4 ↗
Michael Francis MillerChief Technology Officer2026-05-15D2493685CommonForm 4 ↗
Michael Francis MillerChief Technology Officer2026-05-15D83400Derivative, Class A CommonForm 4 ↗
Michael Francis MillerChief Technology Officer2026-05-15D37200Derivative, Class A CommonForm 4 ↗
Michael Francis MillerChief Technology Officer2026-05-15D13600Derivative, Class A CommonForm 4 ↗
Michael Francis MillerChief Technology Officer2026-05-15D8100Derivative, Class A CommonForm 4 ↗
Michael Francis MillerChief Technology Officer2026-05-15D1113305CommonForm 4 ↗
Michael Francis MillerChief Technology Officer2026-05-15A372CommonForm 4 ↗
Michael Francis MillerChief Technology Officer2026-05-15D25369CommonForm 4 ↗
Michael Francis MillerChief Technology Officer2026-05-15D13500Derivative, Class A CommonForm 4 ↗
Vandana SriramChief Financial Officer2026-05-15A514CommonForm 4 ↗
Vandana SriramChief Financial Officer2026-05-15D51400Derivative, Class A CommonForm 4 ↗
Vandana SriramChief Financial Officer2026-05-15D26300Derivative, Class A CommonForm 4 ↗
Michael Francis MillerChief Technology Officer2026-05-15A834CommonForm 4 ↗
Michael Francis MillerChief Technology Officer2026-05-15A136CommonForm 4 ↗
Michael Francis MillerChief Technology Officer2026-05-15D413113CommonForm 4 ↗
Vandana SriramChief Financial Officer2026-05-15A263CommonForm 4 ↗
Vandana SriramChief Financial Officer2026-05-15D793217CommonForm 4 ↗
Vandana SriramChief Financial Officer2026-05-15D1543424CommonForm 4 ↗
Vandana SriramChief Financial Officer2026-05-15D3153866CommonForm 4 ↗
Vandana SriramChief Financial Officer2026-05-15D1,05600Derivative, Class A CommonForm 4 ↗
Michael Francis MillerChief Technology Officer2026-05-31D13000Derivative, Class A CommonForm 4 ↗
Michael Francis MillerChief Technology Officer2026-05-31A130CommonForm 4 ↗
Michael Francis MillerChief Technology Officer2026-05-31D393119CommonForm 4 ↗
Michael Francis MillerChief Technology Officer2026-06-15D25378CommonForm 4 ↗
Michael Francis MillerChief Technology Officer2026-06-15D413127CommonForm 4 ↗
Michael Francis MillerChief Technology Officer2026-06-15D83400Derivative, Class A CommonForm 4 ↗
Michael Francis MillerChief Technology Officer2026-06-15D2493772CommonForm 4 ↗
Michael Francis MillerChief Technology Officer2026-06-15D13500Derivative, Class A CommonForm 4 ↗
Michael Francis MillerChief Technology Officer2026-06-15D37200Derivative, Class A CommonForm 4 ↗
Vandana SriramChief Financial Officer2026-06-15A263CommonForm 4 ↗
Vandana SriramChief Financial Officer2026-06-15D1543477CommonForm 4 ↗
Vandana SriramChief Financial Officer2026-06-15D26300Derivative, Class A CommonForm 4 ↗
Vandana SriramChief Financial Officer2026-06-15D51400Derivative, Class A CommonForm 4 ↗
Vandana SriramChief Financial Officer2026-06-15D1,05600Derivative, Class A CommonForm 4 ↗
Michael Francis MillerChief Technology Officer2026-06-15A136CommonForm 4 ↗
Michael Francis MillerChief Technology Officer2026-06-15A135CommonForm 4 ↗
Michael Francis MillerChief Technology Officer2026-06-15D413127CommonForm 4 ↗
Michael Francis MillerChief Technology Officer2026-06-15A372CommonForm 4 ↗
Michael Francis MillerChief Technology Officer2026-06-15D1113344CommonForm 4 ↗
Michael Francis MillerChief Technology Officer2026-06-15A834CommonForm 4 ↗
Michael Francis MillerChief Technology Officer2026-06-15D8100Derivative, Class A CommonForm 4 ↗
Michael Francis MillerChief Technology Officer2026-06-15D13600Derivative, Class A CommonForm 4 ↗
Vandana SriramChief Financial Officer2026-06-15D793245CommonForm 4 ↗
Vandana SriramChief Financial Officer2026-06-15A1,056CommonForm 4 ↗
Vandana SriramChief Financial Officer2026-06-15A514CommonForm 4 ↗
Vandana SriramChief Financial Officer2026-06-15D3153977CommonForm 4 ↗
Michael Francis MillerChief Technology Officer2026-06-15A81CommonForm 4 ↗
Michael Francis MillerChief Technology Officer2026-06-30A130CommonForm 4 ↗
Michael Francis MillerChief Technology Officer2026-06-30D13000Derivative, Class A CommonForm 4 ↗
Michael Francis MillerChief Technology Officer2026-06-30D394168CommonForm 4 ↗
Scott MendelDirector2026-07-01A3,456414,999CommonForm 4 ↗
William P. DonnellyDirector2026-07-01A5,472423,748CommonForm 4 ↗
Goldman Myla LaiDirector2026-07-08A8,073CommonForm 4 ↗
Scott MendelDirector2026-07-08D8,07300Derivative, Class A CommonForm 4 ↗
Scott MendelDirector2026-07-08A8,073CommonForm 4 ↗
Goldman Myla LaiDirector2026-07-08D8,07300Derivative, Class A CommonForm 4 ↗
Michael Francis MillerChief Technology Officer2026-07-15A136CommonForm 4 ↗
Michael Francis MillerChief Technology Officer2026-07-15D37200Derivative, Class A CommonForm 4 ↗
Michael Francis MillerChief Technology Officer2026-07-15D254106CommonForm 4 ↗
Michael Francis MillerChief Technology Officer2026-07-15D1114471CommonForm 4 ↗
Michael Francis MillerChief Technology Officer2026-07-15A81CommonForm 4 ↗
Michael Francis MillerChief Technology Officer2026-07-15D414174CommonForm 4 ↗
Michael Francis MillerChief Technology Officer2026-07-15D8100Derivative, Class A CommonForm 4 ↗
Michael Francis MillerChief Technology Officer2026-07-15D13600Derivative, Class A CommonForm 4 ↗
Michael Francis MillerChief Technology Officer2026-07-15D24941,056CommonForm 4 ↗
Michael Francis MillerChief Technology Officer2026-07-15D13500Derivative, Class A CommonForm 4 ↗
Michael Francis MillerChief Technology Officer2026-07-15A834CommonForm 4 ↗
Michael Francis MillerChief Technology Officer2026-07-15A372CommonForm 4 ↗
Michael Francis MillerChief Technology Officer2026-07-15D83400Derivative, Class A CommonForm 4 ↗
Jason F. FaesslerChief Financial Officer2026-07-15A141,82000Derivative, Class A CommonForm 4 ↗
Michael Francis MillerChief Technology Officer2026-07-15D414174CommonForm 4 ↗
Michael Francis MillerChief Technology Officer2026-07-15A135CommonForm 4 ↗
03

Grants of plan-based awards — fiscal year 2025

ExecutiveAwardGrant dateThresholdTargetGrantedMaximumGrant-date fair value
William DonnellyRSU2025-01-027,435$80,001
William DonnellyOPTION2025-11-2070,091288,109
Masoud ToloueOPTION2025-02-04454,6412,729,998
Vandana SriramOPTION2025-02-04166,119997,500
Masoud ToloueRSU2025-02-04138,7901,170,000
Vandana SriramRSU2025-02-0450,712427,502
William DonnellyOPTION2025-01-0215,821120,001
03b

Vehicle mix — grant-date fair value by award type

Named executive officerTime-vested (RSU)Performance-vested (PSU)Options / SARs% performance-vested
William Donnelly$80,001$0$408,1100.0%
Masoud Toloue1,170,00002,729,9980.0%
Vandana Sriram427,5020997,5000.0%

% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.

04

Outstanding equity awards at fiscal year-end 2025

ExecutiveAwardShares unvestedExercise priceMarket value unvested
Vandana SriramRSU50,712$322,528
Vandana SriramOption166,1198.43
Vandana SriramOption12,28424.32
Vandana SriramOption44,98923.1
Vandana SriramRSU13,36785,014
Vandana SriramRSU2,80217,821
Vandana SriramRSU5,26033,454
Vandana SriramOption2,40723.9
Vandana SriramOption67,1705.91
05

Incentive-plan design — the Compensation Discussion & Analysis

Our Compensation Committee strives to design and implement executive compensation programs that attract, retain, and motivate our executives, while aligning our executives interests with our business strategy and the interests of our stockholders.

CEO STI target (% of salary)100%
CEO LTI target (% of salary)
Independent consultantPayGov
Clawback policytrue
Anti-hedgingtrue
Anti-pledgingTrue
06

Say-on-pay — recent advisory votes

Meeting yearMeeting dateForAgainstAbstainSupportOutcome
20262026-06-0927,679,6363,881,5162,135,92787.7%Passed
20252025-09-2930,261,4435,546,65187,29884.3%Passed
20242024-06-0325,850,081530,291106,35897.99%Passed
20232023-06-0726,690,270239,91511,80399.11%Passed
20222022-06-2324,271,8222,284,45510,08191.4%Passed

Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year's compensation.

Say-on-pay — history, company's computation

Meeting yearMeeting dateApproval — company's computation
20262026-06-0987.7%a
20252025-09-2984.3%b
20242024-06-0397.99%c

a. Approved under the standard stated in the filing — “​ ​ Abstentions and broker non-votes, if any, will have no effect on the outcome of this proposal.”.

b. Approved under the standard stated in the filing — “​ ​ Abstentions and broker non-votes (if any) will have the effect of a vote "AGAINST" this proposal.”.

c. Approved under the standard stated in the filing — “Abstentions will have no effect on the results of this vote.”.

Approval percentages are the company's own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.

07

CEO pay ratio

Ratio (CEO : median employee)44 : 1
CEO total compensation$5,250,745
Median employee compensation$116,868
08

Director compensation — fiscal year 2025

DirectorCash feesStock awardsOption awardsNon-equity incentiveAll otherTotal
Scott MendelIndependent · Audit · Newly elected$25,190$159,995$239,998$0$0$425,183
Myla Lai-Goldman, M.DIndependent · Compensation · Nominating/Governance · Newly elected12,850159,995239,9980-1412,842
Garret M. Hampton, Ph.DIndependent · Compensation · Audit · Newly elected7,704276,15700-1283,860
Alan Sachs, M.D., Ph.DIndependent · Compensation · Newly elected6,563276,15700-1282,719
Jeffrey T. ElliottIndependent · Lead Independent Director · Audit (Chair) · Nominating/Governance75,36880,001120,00100275,370
Karen A. FlynnIndependent · Compensation (Chair) · Nominating/Governance70,00080,001120,0010-1270,001
Ivana Magovevcic-Liebisch, Ph.D., J.DIndependent · Compensation · Nominating/Governance (Chair)61,21680,001120,0010-1261,217
Paul M. MeisterIndependent · Departed during FY54,68080,001120,0010-1254,681
David R. Walt, Ph.DIndependent · Departed during FY50,93780,001120,00100250,939
Martin D. Madaus, Ph.DIndependent · Departed during FY43,98680,001120,00100243,988
Sarah E. HlavinkaIndependent · Departed during FY36,33280,001120,0010-1236,333
William P. DonnellyEmployee director · Board Chair · Departed during FY00000
Everett CunninghamEmployee director00000
09

Board fee structure and ownership guideline

Annual cash retainer$50,000
Annual equity retainer$200,000
Per board meeting fee
Committee chair fees (audit / comp / nom-gov)10,000 / 7,500 / 5,000
Stock ownership guideline5x annual base cash retainer (non-employee directors); 6x annual base salary (CEO)
09b

Total cost of the board

ComponentFY2025
Cash retainers and fees$444,826
Equity awards (grant-date value)$1,432,311
All other compensation$-7
Total cost of the board$1,877,130

Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.

10

Disclosed peer group — fiscal year 2025

The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.

10a

Peer reciprocity

Of the companies Quanterix Corp names as compensation peers, which name it back in their own disclosed peer groups. A peer set the market reciprocates reads differently from one selected in a single direction.

Reciprocity shown where the peer's own current proxy has been read — each mark is cited in the register to that peer's filing. A dash means the peer's current proxy was read and names no reciprocal group including Quanterix Corp.

10b

Chief executive pay against the peer group

Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.

RankCompanyFYChief executiveSalaryStock awardsOption awardsNon-equity incentiveTotal
1Twist Bioscience Corporation2025Emily Leproust$720,000$11,998,134$0$932,918$13,781,570
2Maravai LifeSciences Holdings, Inc.2025Bernd Brust388,8637,660,0001,460,000425,34310,129,708
3Adaptive Biotechnologies Corporation2025Chad Robins698,2587,675,1000703,3809,081,690
4Standard BioTools Inc.2025Michael Egholm680,2565,337,8831,671,3631,120,0008,823,502
5Veracyte, Inc.2025Marc Stapley700,0005,890,8770826,0007,421,877
6Castle Biosciences, Inc.2025Derek Maetzold751,3504,977,20801,036,8636,786,771
7Mesa Laboratories, Inc.2026Gary Owens808,8464,700,01701,120,0006,643,208
810X Genomics2025Serge Saxonov674,2505,020,2690634,7256,329,244
9Quanterix Corp2025Masoud Toloue670,9501,170,0002,729,998674,1725,250,745
10Cytek Biosciences, Inc.2025Wenbin Jiang620,0002,000,0002,000,000485,2115,120,061
11Pacific Biosciences of California, Inc.2025Christian Henry748,2501,151,0131,696,278714,3054,309,846
12OmniAb, Inc.2025Matthew Foehr620,866640,5002,104,620436,2893,811,740
13Quantum-Si Incorporated2025Jeffrey Hawkins620,8332,000,0000562,5003,183,693
14Cryoport, Inc.2025Jerrell Shelton967,845192,300306,869908,5102,375,524
15Nautilus Biotechnology, Inc.2025Sujal Patel535,0000654,981227,3751,418,556

Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.

10c

Incentive design against the same peers

CompanyAnnual incentive payoutLong-term vehicle mixPSU measures include TSRCompensation consultant
Quanterix Corp95%Options 70 · RSU 30not disclosedPayGov
10X Genomics93%PSU 60 · RSU 40Yes — 3-year Relative TSRAlpine Rewards LLC
Adaptive Biotechnologies Corporation100%RSU 50 · PSU 50NoSemler Brossy Consulting Group, LLC
Castle Biosciences, Inc.138%RSU 50 · PSU 50NoAON (AON's Human Capital Solutions Practice, a division of AON plc)
Cryoport, Inc.92.2%Options 62 · RSU 38not disclosedFrederic W. Cook & Co., Inc.
Cytek Biosciences, Inc.78.4%RSU 50 · Options 50not disclosedMeridian Compensation Partners, LLC
Maravai LifeSciences Holdings, Inc.not disclosednot disclosedNoMeridian Compensation Partners, LLC
Mesa Laboratories, Inc.125%PSU 50 · RSU 50NoFrederic W. Cook & Co, Inc.
Nautilus Biotechnology, Inc.50%Options 100not disclosedCompensia
OmniAb, Inc.not disclosednot disclosednot disclosedAlpine Rewards, LLC
Pacific Biosciences of California, Inc.95%not disclosednot disclosedAon Human Capital Solutions
Quantum-Si Incorporatednot disclosednot disclosednot disclosedAon (January–May 2025); Meridian Compensation Partners (May–December 2025)
Standard BioTools Inc.160%not disclosednot disclosedPearl Meyer
Twist Bioscience Corporation129.6%PSU 50 · RSU 50Nonot disclosed
Veracyte, Inc.118%PSU 50 · RSU 50NoAon

Read from each company's Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company's filing does not state the item.

11

Source register

Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.

#SupportsDocumentFiledAccessionLocation in document
1Section 01, Masoud ToloueDEF 14A2026-04-240001104659-26-048166Section “Summary Compensation Table”. As printed: 5,250,745. Filing ↗machine: t18 · r1 · c47 · span 503076–503085
2Section 01, Vandana SriramDEF 14A2026-04-240001104659-26-048166Section “Summary Compensation Table”. As printed: 2,212,229. Filing ↗machine: r4 · c47 · span 517178–517187
3Section 01, William DonnellyDEF 14A2026-04-240001104659-26-048166Section “Summary Compensation Table”. As printed: 596,842. Filing ↗machine: r7 · c47 · span 530830–530837
4Section 03, William Donnelly RSUDEF 14A2026-04-240001104659-26-048166Section “THE APPROVAL OF THE COMPENSATION OF THE COMPANY&” · grants of plan-based awards table. Filing ↗machine: t17 · r3 · c17 · span 451897–451902
5Section 03, William Donnelly OPTIONDEF 14A2026-04-240001104659-26-048166Section “THE APPROVAL OF THE COMPENSATION OF THE COMPANY&” · grants of plan-based awards table. Filing ↗machine: span 454186–454193
6Section 03, Masoud Toloue OPTIONDEF 14A2026-04-240001104659-26-048166Section “EXECUTIVE OFFICER AND DIRECTOR COMPENSATION” · grants of plan-based awards table. Filing ↗machine: t18 · r1 · c29 · span 501408–501417
7Section 03, Vandana Sriram OPTIONDEF 14A2026-04-240001104659-26-048166Section “THE APPROVAL OF THE COMPENSATION OF THE COMPANY&” · grants of plan-based awards table. Filing ↗machine: t17 · r2 · c17 · span 449681–449688
8Section 03, Masoud Toloue RSUDEF 14A2026-04-240001104659-26-048166Section “EXECUTIVE OFFICER AND DIRECTOR COMPENSATION” · grants of plan-based awards table. Filing ↗machine: t18 · r1 · c23 · span 500855–500864
9Section 03, Vandana Sriram RSUDEF 14A2026-04-240001104659-26-048166Section “THE APPROVAL OF THE COMPENSATION OF THE COMPANY&” · grants of plan-based awards table. Filing ↗machine: t17 · r2 · c11 · span 449174–449180
10Section 03, William Donnelly OPTIONDEF 14A0001104659-26-048166Section “Executive Compensation” · grants of plan-based awards table. Filing ↗
11Section 07, pay ratioDEF 14A2026-04-240001104659-26-048166Section “CEO Pay Ratio”. As printed: 44 : 1. Filing ↗
12Section 08, Scott MendelDEF 14A2026-04-240001104659-26-048166Section “Director Compensation”. As printed: 425,183. Filing ↗machine: t28 · r9 · c29 · span 940580–940587
13Section 08, Myla Lai-Goldman, M.DDEF 14A2026-04-240001104659-26-048166Section “Director Compensation”. As printed: 412,842. Filing ↗machine: t28 · r5 · c29 · span 927034–927041
14Section 08, Garret M. Hampton, Ph.DDEF 14A2026-04-240001104659-26-048166Section “Director Compensation”. As printed: 283,860. Filing ↗machine: t28 · r3 · c29 · span 920484–920491
15Section 08, Alan Sachs, M.D., Ph.DDEF 14A2026-04-240001104659-26-048166Section “Director Compensation”. As printed: 282,719. Filing ↗machine: t28 · r10 · c29 · span 943840–943847
16Section 08, Jeffrey T. ElliottDEF 14A2026-04-240001104659-26-048166Section “Director Compensation”. As printed: 275,370. Filing ↗machine: t28 · r1 · c29 · span 914118–914125
17Section 08, Karen A. FlynnDEF 14A2026-04-240001104659-26-048166Section “Director Compensation”. As printed: 270,001. Filing ↗machine: t28 · r2 · c29 · span 917198–917205
18Section 08, Ivana Magovevcic-Liebisch, Ph.D., J.DDEF 14A2026-04-240001104659-26-048166Section “Director Compensation”. As printed: 261,217. Filing ↗machine: r7 · c29 · span 933432–933439
19Section 08, Paul M. MeisterDEF 14A2026-04-240001104659-26-048166Section “Director Compensation”. As printed: 254,681. Filing ↗machine: t28 · r8 · c29 · span 937283–937290
20Section 08, David R. Walt, Ph.DDEF 14A2026-04-240001104659-26-048166Section “Director Compensation”. As printed: 250,939. Filing ↗machine: t28 · r11 · c29 · span 947122–947129
21Section 08, Martin D. Madaus, Ph.DDEF 14A2026-04-240001104659-26-048166Section “Director Compensation”. As printed: 243,988. Filing ↗machine: t28 · r6 · c29 · span 930293–930300
22Section 08, Sarah E. HlavinkaDEF 14A2026-04-240001104659-26-048166Section “Director Compensation”. As printed: 236,333. Filing ↗machine: t28 · r4 · c29 · span 923741–923748
23Section 08, William P. DonnellyDEF 14A2026-04-240001104659-26-048166Section “Director Compensation”. As printed: 0. Filing ↗
24Section 08, Everett CunninghamDEF 14A2026-04-240001104659-26-048166Section “Director Compensation”. As printed: 0. Filing ↗
25Section 02, Michael Francis Miller 2026-04-30Form 42026-05-010002120516-26-000007Insider equity transaction reported since the proxy statement. Filing ↗
26Section 02, Michael Francis Miller 2026-04-30Form 42026-05-010002120516-26-000007Insider equity transaction reported since the proxy statement. Filing ↗
27Section 02, Michael Francis Miller 2026-04-30Form 42026-05-010002120516-26-000007Insider equity transaction reported since the proxy statement. Filing ↗
28Section 02, Benjamin Meadows 2026-05-12Form 42026-06-120002140394-26-000002Insider equity transaction reported since the proxy statement. Filing ↗
29Section 02, Vandana Sriram 2026-05-15Form 42026-05-180001908223-26-000009Insider equity transaction reported since the proxy statement. Filing ↗
30Section 02, Michael Francis Miller 2026-05-15Form 42026-05-180002120516-26-000008Insider equity transaction reported since the proxy statement. Filing ↗
31Section 02, Michael Francis Miller 2026-05-15Form 42026-05-180002120516-26-000008Insider equity transaction reported since the proxy statement. Filing ↗
32Section 02, Michael Francis Miller 2026-05-15Form 42026-05-180002120516-26-000008Insider equity transaction reported since the proxy statement. Filing ↗
33Section 02, Michael Francis Miller 2026-05-15Form 42026-05-180002120516-26-000008Insider equity transaction reported since the proxy statement. Filing ↗
34Section 02, Michael Francis Miller 2026-05-15Form 42026-05-180002120516-26-000008Insider equity transaction reported since the proxy statement. Filing ↗
35Section 02, Michael Francis Miller 2026-05-15Form 42026-05-180002120516-26-000008Insider equity transaction reported since the proxy statement. Filing ↗
36Section 02, Michael Francis Miller 2026-05-15Form 42026-05-180002120516-26-000008Insider equity transaction reported since the proxy statement. Filing ↗
37Section 02, Michael Francis Miller 2026-05-15Form 42026-05-180002120516-26-000008Insider equity transaction reported since the proxy statement. Filing ↗
38Section 02, Michael Francis Miller 2026-05-15Form 42026-05-180002120516-26-000008Insider equity transaction reported since the proxy statement. Filing ↗
39Section 02, Michael Francis Miller 2026-05-15Form 42026-05-180002120516-26-000008Insider equity transaction reported since the proxy statement. Filing ↗
40Section 02, Michael Francis Miller 2026-05-15Form 42026-05-180002120516-26-000008Insider equity transaction reported since the proxy statement. Filing ↗
41Section 02, Michael Francis Miller 2026-05-15Form 42026-05-180002120516-26-000008Insider equity transaction reported since the proxy statement. Filing ↗
42Section 02, Vandana Sriram 2026-05-15Form 42026-05-180001908223-26-000009Insider equity transaction reported since the proxy statement. Filing ↗
43Section 02, Vandana Sriram 2026-05-15Form 42026-05-180001908223-26-000009Insider equity transaction reported since the proxy statement. Filing ↗
44Section 02, Vandana Sriram 2026-05-15Form 42026-05-180001908223-26-000009Insider equity transaction reported since the proxy statement. Filing ↗
45Section 02, Michael Francis Miller 2026-05-15Form 42026-05-180002120516-26-000008Insider equity transaction reported since the proxy statement. Filing ↗
46Section 02, Michael Francis Miller 2026-05-15Form 42026-05-180002120516-26-000008Insider equity transaction reported since the proxy statement. Filing ↗
47Section 02, Michael Francis Miller 2026-05-15Form 42026-05-180002120516-26-000008Insider equity transaction reported since the proxy statement. Filing ↗
48Section 02, Vandana Sriram 2026-05-15Form 42026-05-180001908223-26-000009Insider equity transaction reported since the proxy statement. Filing ↗
49Section 02, Vandana Sriram 2026-05-15Form 42026-05-180001908223-26-000009Insider equity transaction reported since the proxy statement. Filing ↗
50Section 02, Vandana Sriram 2026-05-15Form 42026-05-180001908223-26-000009Insider equity transaction reported since the proxy statement. Filing ↗
51Section 02, Vandana Sriram 2026-05-15Form 42026-05-180001908223-26-000009Insider equity transaction reported since the proxy statement. Filing ↗
52Section 02, Vandana Sriram 2026-05-15Form 42026-05-180001908223-26-000009Insider equity transaction reported since the proxy statement. Filing ↗
53Section 02, Michael Francis Miller 2026-05-31Form 42026-06-010002120516-26-000009Insider equity transaction reported since the proxy statement. Filing ↗
54Section 02, Michael Francis Miller 2026-05-31Form 42026-06-010002120516-26-000009Insider equity transaction reported since the proxy statement. Filing ↗
55Section 02, Michael Francis Miller 2026-05-31Form 42026-06-010002120516-26-000009Insider equity transaction reported since the proxy statement. Filing ↗
56Section 02, Michael Francis Miller 2026-06-15Form 42026-06-160002120516-26-000011Insider equity transaction reported since the proxy statement. Filing ↗
57Section 02, Michael Francis Miller 2026-06-15Form 42026-06-160002120516-26-000011Insider equity transaction reported since the proxy statement. Filing ↗
58Section 02, Michael Francis Miller 2026-06-15Form 42026-06-160002120516-26-000011Insider equity transaction reported since the proxy statement. Filing ↗
59Section 02, Michael Francis Miller 2026-06-15Form 42026-06-160002120516-26-000011Insider equity transaction reported since the proxy statement. Filing ↗
60Section 02, Michael Francis Miller 2026-06-15Form 42026-06-160002120516-26-000011Insider equity transaction reported since the proxy statement. Filing ↗
61Section 02, Michael Francis Miller 2026-06-15Form 42026-06-160002120516-26-000011Insider equity transaction reported since the proxy statement. Filing ↗
62Section 02, Vandana Sriram 2026-06-15Form 42026-06-230001908223-26-000010Insider equity transaction reported since the proxy statement. Filing ↗
63Section 02, Vandana Sriram 2026-06-15Form 42026-06-230001908223-26-000010Insider equity transaction reported since the proxy statement. Filing ↗
64Section 02, Vandana Sriram 2026-06-15Form 42026-06-230001908223-26-000010Insider equity transaction reported since the proxy statement. Filing ↗
65Section 02, Vandana Sriram 2026-06-15Form 42026-06-230001908223-26-000010Insider equity transaction reported since the proxy statement. Filing ↗
66Section 02, Vandana Sriram 2026-06-15Form 42026-06-230001908223-26-000010Insider equity transaction reported since the proxy statement. Filing ↗
67Section 02, Michael Francis Miller 2026-06-15Form 42026-06-160002120516-26-000011Insider equity transaction reported since the proxy statement. Filing ↗
68Section 02, Michael Francis Miller 2026-06-15Form 42026-06-160002120516-26-000011Insider equity transaction reported since the proxy statement. Filing ↗
69Section 02, Michael Francis Miller 2026-06-15Form 42026-06-160002120516-26-000011Insider equity transaction reported since the proxy statement. Filing ↗
70Section 02, Michael Francis Miller 2026-06-15Form 42026-06-160002120516-26-000011Insider equity transaction reported since the proxy statement. Filing ↗
71Section 02, Michael Francis Miller 2026-06-15Form 42026-06-160002120516-26-000011Insider equity transaction reported since the proxy statement. Filing ↗
72Section 02, Michael Francis Miller 2026-06-15Form 42026-06-160002120516-26-000011Insider equity transaction reported since the proxy statement. Filing ↗
73Section 02, Michael Francis Miller 2026-06-15Form 42026-06-160002120516-26-000011Insider equity transaction reported since the proxy statement. Filing ↗
74Section 02, Michael Francis Miller 2026-06-15Form 42026-06-160002120516-26-000011Insider equity transaction reported since the proxy statement. Filing ↗
75Section 02, Vandana Sriram 2026-06-15Form 42026-06-230001908223-26-000010Insider equity transaction reported since the proxy statement. Filing ↗
76Section 02, Vandana Sriram 2026-06-15Form 42026-06-230001908223-26-000010Insider equity transaction reported since the proxy statement. Filing ↗
77Section 02, Vandana Sriram 2026-06-15Form 42026-06-230001908223-26-000010Insider equity transaction reported since the proxy statement. Filing ↗
78Section 02, Vandana Sriram 2026-06-15Form 42026-06-230001908223-26-000010Insider equity transaction reported since the proxy statement. Filing ↗
79Section 02, Michael Francis Miller 2026-06-15Form 42026-06-160002120516-26-000011Insider equity transaction reported since the proxy statement. Filing ↗
80Section 02, Michael Francis Miller 2026-06-30Form 42026-07-020002120516-26-000012Insider equity transaction reported since the proxy statement. Filing ↗
81Section 02, Michael Francis Miller 2026-06-30Form 42026-07-020002120516-26-000012Insider equity transaction reported since the proxy statement. Filing ↗
82Section 02, Michael Francis Miller 2026-06-30Form 42026-07-020002120516-26-000012Insider equity transaction reported since the proxy statement. Filing ↗
83Section 02, Scott Mendel 2026-07-01Form 42026-07-020001515051-26-000003Insider equity transaction reported since the proxy statement. Filing ↗
84Section 02, William P. Donnelly 2026-07-01Form 42026-07-020001207928-26-000007Insider equity transaction reported since the proxy statement. Filing ↗
85Section 02, Goldman Myla Lai 2026-07-08Form 42026-07-090001168581-26-000002Insider equity transaction reported since the proxy statement. Filing ↗
86Section 02, Scott Mendel 2026-07-08Form 42026-07-090001515051-26-000004Insider equity transaction reported since the proxy statement. Filing ↗
87Section 02, Scott Mendel 2026-07-08Form 42026-07-090001515051-26-000004Insider equity transaction reported since the proxy statement. Filing ↗
88Section 02, Goldman Myla Lai 2026-07-08Form 42026-07-090001168581-26-000002Insider equity transaction reported since the proxy statement. Filing ↗
89Section 02, Michael Francis Miller 2026-07-15Form 42026-07-160002120516-26-000013Insider equity transaction reported since the proxy statement. Filing ↗
90Section 02, Michael Francis Miller 2026-07-15Form 42026-07-160002120516-26-000013Insider equity transaction reported since the proxy statement. Filing ↗
91Section 02, Michael Francis Miller 2026-07-15Form 42026-07-160002120516-26-000013Insider equity transaction reported since the proxy statement. Filing ↗
92Section 02, Michael Francis Miller 2026-07-15Form 42026-07-160002120516-26-000013Insider equity transaction reported since the proxy statement. Filing ↗
93Section 02, Michael Francis Miller 2026-07-15Form 42026-07-160002120516-26-000013Insider equity transaction reported since the proxy statement. Filing ↗
94Section 02, Michael Francis Miller 2026-07-15Form 42026-07-160002120516-26-000013Insider equity transaction reported since the proxy statement. Filing ↗
95Section 02, Michael Francis Miller 2026-07-15Form 42026-07-160002120516-26-000013Insider equity transaction reported since the proxy statement. Filing ↗
96Section 02, Michael Francis Miller 2026-07-15Form 42026-07-160002120516-26-000013Insider equity transaction reported since the proxy statement. Filing ↗
97Section 02, Michael Francis Miller 2026-07-15Form 42026-07-160002120516-26-000013Insider equity transaction reported since the proxy statement. Filing ↗
98Section 02, Michael Francis Miller 2026-07-15Form 42026-07-160002120516-26-000013Insider equity transaction reported since the proxy statement. Filing ↗
99Section 02, Michael Francis Miller 2026-07-15Form 42026-07-160002120516-26-000013Insider equity transaction reported since the proxy statement. Filing ↗
100Section 02, Michael Francis Miller 2026-07-15Form 42026-07-160002120516-26-000013Insider equity transaction reported since the proxy statement. Filing ↗
101Section 02, Michael Francis Miller 2026-07-15Form 42026-07-160002120516-26-000013Insider equity transaction reported since the proxy statement. Filing ↗
102Section 02, Jason F. Faessler 2026-07-15Form 42026-07-160002141457-26-000002Insider equity transaction reported since the proxy statement. Filing ↗
103Section 02, Michael Francis Miller 2026-07-15Form 42026-07-160002120516-26-000013Insider equity transaction reported since the proxy statement. Filing ↗
104Section 02, Michael Francis Miller 2026-07-15Form 42026-07-160002120516-26-000013Insider equity transaction reported since the proxy statement. Filing ↗
105Section 06, 2026 voteForm 8-K2026-06-100001503274-26-000028Item 5.07 · say-on-pay result. As reported: 87.7% (votes for as printed: 27,679,636). Filing ↗
106Section 06, 2025 voteForm 8-K2025-10-020001503274-25-000097Item 5.07 · say-on-pay result. As reported: 84.3% (votes for as printed: 30,261,443). Filing ↗
107Section 06, 2024 voteForm 8-K2024-06-070001104659-24-069615Item 5.07 · say-on-pay result. As reported: 97.99% (votes for as printed: 25,850,081). Filing ↗
108Section 01 trend, Δ column (computed)ComputedcomputedΔ = current-FY total − prior-FY total per named officer.machine: formula: Δ = FY(n) − FY(n−1)
109Section 03b vehicle mix (computed)ComputedcomputedRSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).machine: formula: sums + PSU ratio
110Section 09b board cost (computed)ComputedcomputedCash 444,826 + equity 1,432,311 + all other -7 = 1,877,130, summed across the director compensation table rows.machine: formula: Σ = 1,877,130
111Twist Bioscience Corporation, Section 10b CEO totalDEF 14A2026-01-060001581280-26-000006CEO total compensation as printed in Twist Bioscience Corporation's own proxy. As printed: 13,781,570. Filing ↗machine: t34 · r2 · c15 · span 1510951–1510961
112Maravai LifeSciences Holdings, Inc., Section 10b CEO totalDEF 14A2026-04-240001823239-26-000014CEO total compensation as printed in Maravai LifeSciences Holdings, Inc.'s own proxy. As printed: 10,129,708. Filing ↗machine: t21 · r3 · c20 · span 502645–502655
113Adaptive Biotechnologies Corporation, Section 10b CEO totalDEF 14A2026-04-240001193125-26-177409CEO total compensation as printed in Adaptive Biotechnologies Corporation's own proxy. As printed: 9,081,690. Filing ↗machine: span 818708–818717
114Standard BioTools Inc., Section 10b CEO totalDEF 14A2026-04-270001140361-26-017100CEO total compensation as printed in Standard BioTools Inc.'s own proxy. As printed: 8,823,502. Filing ↗machine: r2 · c22 · span 553256–553266
115Veracyte, Inc., Section 10b CEO totalDEF 14A2026-04-220001384101-26-000021CEO total compensation as printed in Veracyte, Inc.'s own proxy. As printed: 7,421,877. Filing ↗machine: r4 · c27 · span 855413–855422
116Castle Biosciences, Inc., Section 10b CEO totalDEF 14A2026-04-080001628280-26-024166CEO total compensation as printed in Castle Biosciences, Inc.'s own proxy. As printed: 6,786,771. Filing ↗machine: r3 · c24 · span 933087–933096
117Mesa Laboratories, Inc., Section 10b CEO totalDEF 14A2026-07-220000724004-26-000071CEO total compensation as printed in Mesa Laboratories, Inc.'s own proxy. As printed: 6,643,208. Filing ↗machine: r3 · c24 · span 580946–580955
11810X Genomics, Section 10b CEO totalDEF 14A2026-04-240001628280-26-027201CEO total compensation as printed in 10X Genomics's own proxy. As printed: 6,329,244. Filing ↗machine: r3 · c48 · span 583283–583292
119Quanterix Corp (subject), Section 10b CEO totalDEF 14A2026-04-240001104659-26-048166CEO total compensation as printed in Quanterix Corp's own proxy. As printed: 5,250,745. Filing ↗machine: t18 · r1 · c47 · span 503076–503085
120Cytek Biosciences, Inc., Section 10b CEO totalDEF 14A2026-04-280001140361-26-017479CEO total compensation as printed in Cytek Biosciences, Inc.'s own proxy. As printed: 5,120,061. Filing ↗machine: r2 · c21 · span 561243–561252
121Pacific Biosciences of California, Inc., Section 10b CEO totalDEF 14A2026-04-230001299130-26-000064CEO total compensation as printed in Pacific Biosciences of California, Inc.'s own proxy. As printed: 4,309,846. Filing ↗machine: r2 · c48 · span 876974–876983
122OmniAb, Inc., Section 10b CEO totalDEF 14A2026-04-290001846253-26-000027CEO total compensation as printed in OmniAb, Inc.'s own proxy. As printed: 3,811,740. Filing ↗machine: span 342457–342466
123Quantum-Si Incorporated, Section 10b CEO totalDEF 14A2026-04-010001816431-26-000021CEO total compensation as printed in Quantum-Si Incorporated's own proxy. As printed: 3,183,693. Filing ↗machine: r2 · c54 · span 238204–238213
124Cryoport, Inc., Section 10b CEO totalDEF 14A2026-04-220001140361-26-016129CEO total compensation as printed in Cryoport, Inc.'s own proxy. As printed: 2,375,524. Filing ↗machine: t277 · r2 · c22 · span 1285130–1285139
125Nautilus Biotechnology, Inc., Section 10b CEO totalDEF 14A2026-04-280001808805-26-000023CEO total compensation as printed in Nautilus Biotechnology, Inc.'s own proxy. As printed: 1,418,556. Filing ↗machine: r2 · c42 · span 312886–312895
126Section 10a, Standard BioTools Inc. reciprocityDEF 14A0001140361-26-017100Standard BioTools Inc. names Quanterix Corp in its own disclosed peer group (read from its most recent proxy). Filing ↗
127Section 10a, Cytek Biosciences, Inc. reciprocityDEF 14A0001140361-26-017479Cytek Biosciences, Inc. names Quanterix Corp in its own disclosed peer group (read from its most recent proxy). Filing ↗
128Section 10a, Veracyte, Inc. reciprocityDEF 14A0001384101-26-000021Veracyte, Inc.'s most recent proxy was read; its disclosed peer group does not include Quanterix Corp. Filing ↗
129Section 10a, Pacific Biosciences of California, Inc. reciprocityDEF 14A0001299130-26-000064Pacific Biosciences of California, Inc. names Quanterix Corp in its own disclosed peer group (read from its most recent proxy). Filing ↗
130Section 10a, Castle Biosciences, Inc. reciprocityDEF 14A0001628280-26-024166Castle Biosciences, Inc.'s most recent proxy was read; its disclosed peer group does not include Quanterix Corp. Filing ↗
131Section 10a, 10X Genomics reciprocityDEF 14A0001628280-26-02720110X Genomics's most recent proxy was read; its disclosed peer group does not include Quanterix Corp. Filing ↗
132Section 10a, Maravai LifeSciences Holdings, Inc. reciprocityDEF 14A0001823239-26-000014Maravai LifeSciences Holdings, Inc.'s most recent proxy was read; its disclosed peer group does not include Quanterix Corp. Filing ↗
133Section 10a, Mesa Laboratories, Inc. reciprocityDEF 14A0000724004-26-000071Mesa Laboratories, Inc. names Quanterix Corp in its own disclosed peer group (read from its most recent proxy). Filing ↗
134Section 10a, OmniAb, Inc. reciprocityDEF 14A0001846253-26-000027OmniAb, Inc.'s most recent proxy was read; its disclosed peer group does not include Quanterix Corp. Filing ↗
135Section 10a, Adaptive Biotechnologies Corporation reciprocityDEF 14A0001193125-26-177409Adaptive Biotechnologies Corporation names Quanterix Corp in its own disclosed peer group (read from its most recent proxy). Filing ↗